US biomedical research: basic, translational, and clinical sciences.

The National Institutes of Health (NIH) is the world's largest biomedical research agency, with a 75-year record of responding to the nation's key medical challenges. Today, medical science is entering a revolutionary period marked by a shift in focus from acute to chronic diseases, rapidly escalating health care costs, a torrent of biological data generated by the sequencing of the human genome, and the development of advanced high-throughput technologies that allow for the study of vast molecular networks in health and disease. This unique period offers the unprecedented opportunity to identify individuals at risk of disease based on precise molecular knowledge, and the chance to intervene to preempt disease before it strikes. Conceptually, this represents the core scientific challenge of the coming century. The NIH is committed to the discoveries that will change the practice of medicine as we know it in order to meet this challenge. The NIH Roadmap constitutes an important vehicle for generating change-a most critical element of this plan is the reengineering of the national clinical research enterprise. This reinvention will call for the transformation of translational clinical science and for novel interdisciplinary approaches that will advance science and enhance the health of the nation.

[1]  G. Greene The Heart of the Matter , 1948 .

[2]  G. Pascal Zachary Endless Frontier: Vannevar Bush, Engineer of the American Century , 1997 .

[3]  A. Sanchez,et al.  Development of a preventive vaccine for Ebola virus infection in primates , 2000, Nature.

[4]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[5]  Anthony S Fauci,et al.  HIV and AIDS: 20 years of science , 2003, Nature Medicine.

[6]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[7]  R. Koup,et al.  Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates , 2003, Nature.

[8]  E. Zerhouni The NIH Roadmap , 2003, Science.

[9]  C. Mello,et al.  Inducible systemic RNA silencing in Caenorhabditis elegans. , 2003, Molecular biology of the cell.

[10]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[11]  Gary J. Nabel,et al.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice , 2004, Nature.

[12]  H. Paulson,et al.  RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia , 2004, Nature Medicine.

[13]  P. Earl,et al.  Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Robert C. Liddington,et al.  Crystal structure of a complex between anthrax toxin and its host cell receptor , 2004, Nature.

[15]  P. Earl,et al.  Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox , 2004, Nature.

[16]  Bernardo A Mangiola,et al.  A Drosophila protein-interaction map centered on cell-cycle regulators , 2004, Genome Biology.

[17]  J. Beiser,et al.  The Ocular Hypertension Treatment Study Topical Medication Delays or Prevents Primary Open-angle Glaucoma in African American Individuals , 2004 .

[18]  Barry R. Davis,et al.  Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril , 2005 .

[19]  J. Lieberman,et al.  The prospect of silencing disease using RNA interference. , 2005, JAMA.

[20]  W. Greene,et al.  Studies of Ebola Virus Glycoprotein-Mediated Entry and Fusion by Using Pseudotyped Human Immunodeficiency Virus Type 1 Virions: Involvement of Cytoskeletal Proteins and Enhancement by Tumor Necrosis Factor Alpha , 2005, Journal of Virology.

[21]  E. Nabel,et al.  Ebola Virus Glycoprotein Toxicity Is Mediated by a Dynamin-Dependent Protein-Trafficking Pathway , 2005, Journal of Virology.

[22]  S. Whelan,et al.  Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection , 2005, Science.